These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 29084148)

  • 21. Keeping up appearances: Don't frown upon the effects of botulinum toxin injections in facial muscles.
    Punga AR; Alimohammadi M; Liik M
    Clin Neurophysiol Pract; 2023; 8():169-173. PubMed ID: 37681120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cosmetic denervation of the muscles of facial expression with botulinum toxin. A dose-response study.
    Garcia A; Fulton JE
    Dermatol Surg; 1996 Jan; 22(1):39-43. PubMed ID: 8556256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Forehead Movement Discrepancies After Botulinum Toxin Injections: A Review of Etiology, Correction, and Prevention.
    Walker B; Hand M; Chesnut C
    Dermatol Surg; 2022 Jan; 48(1):94-100. PubMed ID: 34537780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relevance of sonography for botulinum toxin treatment of cervical dystonia: an expert statement.
    Schramm A; Bäumer T; Fietzek U; Heitmann S; Walter U; Jost WH
    J Neural Transm (Vienna); 2015 Oct; 122(10):1457-63. PubMed ID: 25547861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of blepharospasm and facial hemispasm by injection of botulinum toxin].
    Saraux H
    J Fr Ophtalmol; 1988; 11(3):237-40. PubMed ID: 3418019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of blepharospasm and facial hemispasm with botulinum toxin. Apropos of 58 injections in 22 patients].
    Elbaz D
    Ann Otolaryngol Chir Cervicofac; 1994; 111(3):141-4. PubMed ID: 7840486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regional diffusion of botulinum toxin in facial muscles: a randomised double-blind study and a consideration for clinical studies with split-face design.
    Punga AR; Eriksson A; Alimohammadi M
    Acta Derm Venereol; 2015 Nov; 95(8):948-51. PubMed ID: 25766591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of Botulinum toxin on the detection of gradual changes in facial emotion.
    Bulnes LC; Mariën P; Vandekerckhove M; Cleeremans A
    Sci Rep; 2019 Aug; 9(1):11734. PubMed ID: 31409880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
    Bhidayasiri R; Cardoso F; Truong DD
    Eur J Neurol; 2006 Feb; 13 Suppl 1():21-9. PubMed ID: 16417594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of facial spasm with botulin A toxin].
    Adenis JP; Smolik I; Maes S
    J Fr Ophtalmol; 1990; 13(5):259-64. PubMed ID: 2258549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Temporomandibular Myofacial Pain Treated with Botulinum Toxin Injection.
    Mor N; Tang C; Blitzer A
    Toxins (Basel); 2015 Jul; 7(8):2791-800. PubMed ID: 26213970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depression--An emerging indication for botulinum toxin treatment.
    Kruger TH; Wollmer MA
    Toxicon; 2015 Dec; 107(Pt A):154-7. PubMed ID: 26415901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical differences between botulinum neurotoxin type A and B.
    Bentivoglio AR; Del Grande A; Petracca M; Ialongo T; Ricciardi L
    Toxicon; 2015 Dec; 107(Pt A):77-84. PubMed ID: 26260691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin in the treatment of hemifacial spasm.
    Chong PN
    Singapore Med J; 1990 Oct; 31(5):469-71. PubMed ID: 2259946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Half-mirror biofeedback exercise in combination with three botulinum toxin A injections for long-lasting treatment of facial sequelae after facial paralysis.
    Lee JM; Choi KH; Lim BW; Kim MW; Kim J
    J Plast Reconstr Aesthet Surg; 2015 Jan; 68(1):71-8. PubMed ID: 25444667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Botulinum toxin: the misguided path].
    Harth W
    Hautarzt; 2013 Jun; 64(6):410-3. PubMed ID: 23636411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical application of botulinum toxin].
    Mezaki T
    Brain Nerve; 2011 Jul; 63(7):785-94. PubMed ID: 21747149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term efficacy, safety, and side effect profile of botulinum toxin in dystonia: a 20-year follow-up.
    Ramirez-Castaneda J; Jankovic J
    Toxicon; 2014 Nov; 90():344-8. PubMed ID: 25130293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aesthetic uses of the botulinum toxin.
    Dorizas A; Krueger N; Sadick NS
    Dermatol Clin; 2014 Jan; 32(1):23-36. PubMed ID: 24267419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postmarketing safety surveillance data reveals antidepressant effects of botulinum toxin across various indications and injection sites.
    Makunts T; Wollmer MA; Abagyan R
    Sci Rep; 2020 Jul; 10(1):12851. PubMed ID: 32732918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.